Strategies Adopted by the Major Players in this Digital PCR Market
According to research report the Digital PCR Market is expected to grow from USD 3.47 billion in 2017 to USD 5.31 billion by 2022, at a CAGR of 8.9% during the forecast period.Product Launches: Key Strategy Adopted by the Major Players in this MarketNew product launches and approvals are the key growth strategies adopted
by major players to strengthen their position in the global Digital PCR
Market. Moreover, strategies such as partnerships, collaborations, and
agreements; as well as mergers and acquisitions were also adopted by
several market players to strengthen their market position, expand their
R&D capabilities, and geographic presence in the global Digital PCR
Market.
The key players in the Digital PCR Market include Thermo Fisher
Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad
Laboratories, Inc. (US), QIAGEN N.V. (Netherlands), Takara Bio, Inc.
(Japan), Agilent Technologies, Inc. (US), bioMérieux S.A. (France),
Fluidigm Corporation (US), Danaher Corporation (US), Abbott Laboratories
(US), Merck KGaA (Germany), Promega Corporation (US), Becton, Dickinson
and Company (US), Meridian Bioscience, Inc. (US), and Analytik Jena AG
(Germany), among others.
Comments
Post a Comment